ERBB2 and neoplasm: To determine if the permeability increase in metastatic brain tumors by the PDE5 inhibitors can be translated into improved efficacy of tumor therapy, Herceptin was administered to mice with brain-implanted lung metastatic CRL-5904 and breast cancer BT-474 tumors positive for HER2/neu.